Aurobindo completes deal to acquire Apotex' European businesses
- Country:
- India
Aurobindo Pharma Monday said it has completed the EUR 74-million deal to acquire Apotex’s commercial operations and certain supporting infrastructure in five European countries. The company had inked a binding agreement on July 14, 2018, to acquire five of Apotex' European businesses, including infrastructure, personnel, products, certain established trademarks, marketing authorisations and dossier licence rights in Poland, the Czech Republic, the Netherlands, Spain and Belgium, Aurobindo Pharma said in a regulatory filing.
This announcement does not constitute a recommendation to shareholders or potential investors, it added. Aurobindo Pharma shares were trading 0.94 per cent down at Rs 753.50 apiece on the BSE.
(With inputs from agencies.)
- READ MORE ON:
- Aurobindo Pharma
- European cuisine
- European Parliament
- European Commission
- Dairy product
- Hairstyling product
- gap personnel
- Extra Personnel
- Partners Personnel Services
- Small business
- Business plan
- Shareholders' agreement
- Board of directors
- Share price
- President of Poland
- Invasion of Poland
- Poland Spring
- Czech Republic
- Czech koruna
- Czech Language
ALSO READ
Viral video of CEO recommending stocks is deep fake: National Stock Exchange cautions investors
UK equities end volatile session higher as investors ponder rate outlook
Poland won't accept migrant relocation mechanism, PM says
Poland won't accept migrant relocation mechanism, PM says
UPDATE 1-Australia's Santos shareholders re-elect Keith Spence as chair